Human brain

The brain is the most complicated object in the universe. This is the story of scientists’ quest to decode it – and read people’s minds

Retrieved on: 
Wednesday, February 7, 2024

This is the closest science has yet come to reading someone’s mind.

Key Points: 
  • This is the closest science has yet come to reading someone’s mind.
  • As Alexander Huth, the neuroscientist who co-led the research, told the New York Times:
    This isn’t just a language stimulus.
  • In the longer term, this could lead to wider public applications such as fitbit-style health monitors for the brain and brain-controlled smartphones.
  • On January 29, Elon Musk announced that his Neuralink tech startup had implanted a chip in a human brain for the first time.

Humanity’s greatest mapping challenge

  • By fully mapping the structure and function of a healthy human brain, we can determine with great precision what goes awry in diseases of the brain and mind.
  • Similar initiatives were launched in Europe in 2013 (the Human Brain Project) and China in 2016 (the China Brain Project).
  • This daunting endeavour may still take generations to complete – but the scientific ambition of mapping and reading people’s brains dates back more than two centuries.
  • With the world having been circumnavigated many times over, Antarctica discovered and much of the planet charted, humanity was ready for a new (and even more complicated) mapping challenge – the human brain.
  • In the 1860s, “locationist” views of how the brain worked made a comeback – though the scientists leading this research were keen to distinguish their theories from phrenology.
  • French anatomist Paul Broca discovered a region of the left hemisphere responsible for producing speech – thanks in part to his patient, Louis Victor Leborgne, who at age 30 lost the ability to say anything other than the syllable “tan”.
  • This approach depends on the findings of American physiologist John Fulton almost a century ago.
  • This stronger pulse of activity was not replicated by other sensory inputs, for example when smelling tobacco or vanilla.

The first clinical trial

  • The ultimate goal is wireless, non-invasive devices that help patients communicate and move with precision in the real world.
  • In 2004, BrainGate began the first clinical trial using BCIs to enable patients with impaired motor systems (including spinal cord injuries, brainstem infarctions, locked-in syndrome and muscular dystrophy) control a computer cursor with their thoughts.
  • The team is working with academics from different backgrounds who have been engaged in projects aimed at tackling societal and scientific challenges.
  • Patient MN, a quadriplegic since being stabbed in the neck in 2001, was the trial’s first patient.
  • In addition, brain activity was linked to the patient’s prosthetic hand and robotic arm, enabling rudimentary actions including grasping and transporting an object.
  • Also in 2017, BrainGate clinical trials reported the first evidence that BCIs could be used to help patients regain movement of their own limbs by bypassing the damaged portion of the spinal cord.

A new era of ‘mind reading’ technology

  • But having been primarily envisaged as a tool for diagnostics and monitoring, it is now also a core element of the latest neural communication and prosthetic devices.
  • Despite being behaviourally non-responsive and minimally conscious, these patients were able to answer yes-or-no questions just by using their minds.
  • Now, a decade on, the HuthLab research at the University of Texas constitutes a paradigmatic shift in the evolution of communication-enabling neuroimaging systems.
  • Whereas the brain’s capacity to produce motor intentions is shared across species, the ability to produce and perceive language is uniquely human.
  • The disadvantage of fMRI is that it can only take slow measurements of brain signals (typically, one brain volume every two or three seconds).
  • They demonstrated that the system could be used not only to decode semantic content entertained through auditive perception, but also through visual perception.
  • Importantly, they also explicitly addressed the potential threat to a person’s mental privacy posed by this kind of technology.
  • We take very seriously the concerns that it could be used for bad purposes and have worked to avoid that.

The ethical implications are immense

  • Losing the ability to communicate is a deep cut to one’s sense of self.
  • The ethical implications of providing access to such data to scientific and corporate entities are potentially immense.
  • For example, Parkinson’s disease, a neurodegenerative disease that affects movement, is co-morbid with dementia, which affects the ability to reason and think clearly.
  • In line with this approach, Chile was the first country that adopted legislation to address the risks inherent to neurotechnology.
  • One of the cornerstones of ethical research is the principle of informed consent.
  • The growing availability of neurotechnology in a commercial context that is generally subject to far less regulation only amplifies these ethical and legal concerns.
  • We are at an early stage of technological development and as we begin to uncover the great potential of BCI, both for therapeutic applications and beyond, the need to consider these ethical questions and their implications for legal action becomes more pressing.

Decoding our neuro future

  • By the middle of 2021, the total investment in neurotechnology companies amounted to just over US$33 billion (around £26 million).
  • The implant is said to include 1,024 electrodes, yet is only slightly larger than the diameter of a red blood cell.
  • The Kernel Flow, for example, is a commercially available, wearable headset that uses fNRIS technology to monitor brain activity.
  • The dawn of a new era of brain-computer interfaces should be treated with great care and great respect – in acknowledgement of its immense potential to both help, and harm, our future generations.


For you: more from our Insights series:
Unlocking new clues to how dementia and Alzheimer’s work in the brain – Uncharted Brain podcast series

Freedom of thought is being threatened by states, big tech and even ourselves. Here’s what we can do to protect it

OCD is so much more than handwashing or tidying. As a historian with the disorder, here’s what I’ve learned

Noise in the brain enables us to make extraordinary leaps of imagination. It could transform the power of computers too

To hear about new Insights articles, join the hundreds of thousands of people who value The Conversation’s evidence-based news. Subscribe to our newsletter.
Stephanie Sheir received funding from the EPSRC (grant number EP/V026518/1). Timo Istace receives funding from Fonds Wetenschappelijk Onderzoek Vlaanderen. Nicholas J. Kelley does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Announcing the Launch of a New Book, Entitled "Artificial General Intelligence: A Revolution Beyond Deep Learning and The Human Brain"

Retrieved on: 
Tuesday, January 2, 2024

New Book by Brent Oster and Gunnar Newquist Promises to Reshape the Future of AI

Key Points: 
  • Santa Clara, California--(Newsfile Corp. - January 2, 2024) - New book, "Artificial General Intelligence: A Revolution Beyond Deep Learning and The Human Brain" by Brent Oster and Gunnar Newquist, two industry experts, is proud to announce its recent launch.
  • This groundbreaking book offers an in-depth exploration of the next frontier in artificial intelligence.
  • "Artificial General Intelligence: A Revolution Beyond Deep Learning and The Human Brain" was released on December 21, 2023 and is available through Amazon Kindle Books .
  • Join the conversation and be part of the AGI revolution by ordering a copy today.

Cerevance Announces Presentation at the XVI European Meeting on Glial Cells in Health and Disease

Retrieved on: 
Wednesday, June 28, 2023

BOSTON, June 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system (CNS) diseases using the company’s proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform, today announced plans to present a poster presentation at the upcoming XVI European Meeting on Glial Cells in Health and Disease, taking place in Berlin, Germany, July 8 – July 11, 2023.

Key Points: 
  • BOSTON, June 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system (CNS) diseases using the company’s proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform, today announced plans to present a poster presentation at the upcoming XVI European Meeting on Glial Cells in Health and Disease, taking place in Berlin, Germany, July 8 – July 11, 2023.
  • Title: NETSseq Provides Deep Molecular Insight Into Astrocyte Biology, Identifying Complex Regional and State Dependent Heterogeneity in the Human Brain
    Overview: Cerevance’s proprietary NETSseq platform has generated highly reproducible molecular profiles of many specific neuronal and glial cell types (>60) from human brains.
  • Using machine learning techniques, the regional and state dependent heterogeneity in human astrocytes is better understood and leveraged to help to define the role of these cells in disease and identify cell type specific targets for drug discovery.

Atomic Entertainment Launches Innovative Learning Platform to Boost Elementary Education

Retrieved on: 
Wednesday, July 20, 2022

"Our goal is to use the power of entertainment-based education to inspire the curiosity of millions of elementary students. Our carefully crafted content explores key knowledge-building subjects through things kids love, like rollercoasters, pizza, video games, and the ocean. By connecting super clever and insanely fun scripted stories to stuff kids are already wild about -- kids get to have a great time without even realizing how much they're learning," said Jerry Kolber, CEO/Co-Founder of Atomic Entertainment and Host of "Who Smarted?"

Key Points: 
  • The video adventure platform puts children front and center in a dynamic and highly entertaining learning experience.
  • The courses are designed with the latest research from the fields of child psychology and education, to ensure maximum enjoyment and lasting knowledge retention.
  • "Our goal is to use the power of entertainment-based education to inspire the curiosity of millions of elementary students.
  • Atomic Entertainment develops a range of learning tools for one purpose: to create educational content so insanely engaging that you don't even realize you're learning!

Full Steam Ahead for Science as South Florida Science Center Receives $20 Million Dollar Lead Gift and a New Name

Retrieved on: 
Monday, November 15, 2021

The Cox's gift is the largest single gift in the Center's 60-year history and serves as the keystone for a $45 million expansion campaign.

Key Points: 
  • The Cox's gift is the largest single gift in the Center's 60-year history and serves as the keystone for a $45 million expansion campaign.
  • The group assembled outdoors at the Center's Cox Amphitheater for a front-row seat to the history-making news as they ceremoniously unveiled the new Cox Science Center logo.
  • "This transformative gift will allow us to offer Palm Beach County residents and visitors the Science Center they deserve," said Arrizza.
  • For information on supporting the Cox Science Center and Aquarium's capital campaign, visit www.CoxScienceCenter.org/Support-Us or contact Marcy Hoffman at [email protected] .

Global Brain Tumor Drugs Market Report 2021-2025 & Long-term Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 23, 2021

The "Brain Tumor Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Brain Tumor Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the brain tumor drugs market are Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., and AstraZeneca.
  • The brain tumor drugs market consists of sales of drugs which are used to cure a mass growth of abnormal cells in the human brain.
  • Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity

Retrieved on: 
Wednesday, June 2, 2021

Their experience in the field will be indispensable to the Company in developing a product that allows neurologists to record brain activity and ablate targeted brain tissue in the same procedure.

Key Points: 
  • Their experience in the field will be indispensable to the Company in developing a product that allows neurologists to record brain activity and ablate targeted brain tissue in the same procedure.
  • The electrode is also expected to save time, cost and potentially improve outcomes, adding value to both patients and physicians that could benefit from this technology."
  • In partnership with Mayo Clinic, Wisconsin Alumni Research Foundation (WARF) and other prominent academic medical centers, the Company began developing its cortical electrode technology in 2015.
  • NeuroOne intends to continue to develop the technology for use in therapeutic applications for Parkinson's disease, epilepsy and pain management due to failed back surgery procedures.

Surgical Information Sciences Announces FDA 510(k) Clearance for Additional Anatomical Structures for its DBS Visualization Software

Retrieved on: 
Monday, April 5, 2021

The updated algorithm and new capabilities enhance theindustry-leading features of the SIS System, including:

Key Points: 
  • The updated algorithm and new capabilities enhance theindustry-leading features of the SIS System, including:
    The STN and GPi/GPe are key targets for patients with Parkinson's disease.
  • "The SIS System provides the only patient specific and most accurate tool for visualizing brain anatomy for DBS surgical planning.
  • With this new FDA clearance, we will now shift focus to applying the CE Mark and having the ability to commercialize in the key DBS markets around the world.
  • SIS has developed a patented, stateoftheart, clinically validated, patientspecific solution for the visualization of brain structures to be used in surgical planning in order to accurately determine the target location for DBS surgery.

Study Maps Key Proteins Linked to Epilepsy, Revealing New Drug Targets

Retrieved on: 
Tuesday, March 9, 2021

NEW YORK, March 9, 2021 /PRNewswire/ -- An analysis of adult human brain tissue reveals over 900 proteins tied to epilepsy.

Key Points: 
  • NEW YORK, March 9, 2021 /PRNewswire/ -- An analysis of adult human brain tissue reveals over 900 proteins tied to epilepsy.
  • Study results showed that altered levels of brain proteins predominated in the hippocampus, a structure located deep inside the skull and responsible for memory and learning.
  • Wisniewski says the NYU Langone team has plans to create a database that depicts "the brain landscape" of epilepsy protein and gene targets.
  • Funding for the study was provided by National Institutes of Health grants U01 NS090415, P30 AG066512, P01 AG060882, and S10 OD010582.

Can Brain Implants Improve Mobility After Stroke?

Retrieved on: 
Monday, February 1, 2021

When it happens, blood clots or bleeds kill a part of the brain it goes dark and can no longer control part of the body.

Key Points: 
  • When it happens, blood clots or bleeds kill a part of the brain it goes dark and can no longer control part of the body.
  • "This study serves as a proof of concept, a necessary bridge to future studies that would use fully implanted wireless electrodes to improve movement after stroke."
  • In those patients, electrodes that recorded brain signals were implanted in the brain tissue and connected by wires extending through the skull to a computer.
  • But those abilities were only available to the patients as long as the brain implants were in place.